Ahora hay que ver si finalmente sube el precio de la miel de Ulmo y las otras que producimos en el Bosque Valdiviano muchos apicultores chilenos. Si es chileno es bueno, aunque el negocio lo hagan los extranjeros.Otra del señor Corchete:
Scientists have discovered a remarkable ultra-pure honey which can kill MRSA and other lethal antibiotic-resistant bugs.
The sweet food can be used as a potent cream or added to wound dressings to blast stubborn bacteria.
Researchers believe it will transform the treatment of virulent hospital infections such as MRSA and E.coli and be on the market within two years.
It could also be put into sore throat lozenges or medicated chewing gum.
Dr James Brennan, who is working with a team of scientists in Ireland at Healing Honey International, said: "This is a natural product with supernatural powers. It's like a shotgun that blows micro-organisms out of the water.
"It has worked in thousands of trials and has the potential to reduce MRSA in hospitals significantly.
"It can kill particularly virulent bugs that antibiotics and conventional antiseptics are failing to have an effect on."
He added: "I have been a practising scientist for a number of years and it is very rare that you get the opportunity to say, 'Wow'. But this is a genuinely exciting breakthrough that could make a great contribution to world health."
Grown in an isolated region of southern Chile, the honey - called ActiveH2O2NEY - was found and developed by British horticulturist and beekeeper Ian Staples, 63.
It is free from pollutants and contains a range of natural properties including hydrogen peroxide.
Patente en NZ
| Company Name: | HEALING HONEY INTERNATIONAL LTD |
| Company Number: | 07146235 |
| Company Address: | 8 KING EDWARD STREET OXFORD OX1 4HL |
| Company Type: | Private Limited Company |
| Company Status: | Active |
| Company Industry: | None Supplied |
Manuka Honey as a wound treatment
A HRB-funded project, examining the use of honey in the healing of wounds has made a potentially significant breakthrough in the battle against chronic wounds. Dr. Georgina Gethin initiated the study when she was a Clinical Nurse Specialist in Sligo General Hospital and was awarded a HRB Fellowship to conduct a RCT (Randomised Controlled Trial) using Manuka honey in the treating of chronic leg ulcers.
The effects of Active Manuka honey in the cleansing (debridement) and healing rates of wounds, as well as in antimicrobial activity, were compared to the effects of a standard hydrogel, both under compression, over a 12-week period. After the treatment period, it was determined that the group treated with honey experienced a higher rate of debridement (removal of dead, damaged, or infected tissue), significantly faster healing and reduced infection than in the group treated with the standard gel. Particularly striking in the study, was the information about effectiveness of Active Manuka Honey on wounds with Methicillin-resistant Staphylo
The Bussiness of Research
http://issuu.com/entirl/docs/
AN IRISH college has discovered there's money in honey
Sligo Institute of Technology has just signed a licensing agreement with a leading American company following research it conducted into manuka honey -- believed to have unique healing powers.
The institute research team isolated the curative properties of the honey and showed how they could be produced synthetically. Now HemCon plans to use the discovery for wound care, control of hospital-acquired infections and oral hygiene applications. It's also looking at other uses such as teeth whitening.
The research deal is worth at least $1m a year in royalties over the next 12 years to the Sligo Institute. Some of this will be ploughed back into further research and development at the institute.
The manuka discovery was made by a three-member research at the institute -- Drs James Brennan, John Barrett and Tom Patton.
"During their research into the curative properties of manuka honey they almost by accident discovered a particular synthetic way to produce the same effect and they were able to isolate this" said Niall McEvoy, innovation manager at the Institute.
HemCon, based in Portland, Oregon, aims to commercialise the product. Mr McEvoy said it was examining the possibility of the base product being manufactured in Sligo.
http://www.sligotoday.ie/
Algunas de las Patentes del equipo irlandes Sligo
http://www.wipo.int/pctdb/en/
http://www.freepatentsonline.
La compañia que les compró la idea
No hay comentarios.:
Publicar un comentario